Meiragtx Holdings PLC Form 4 insider transactions

MeiraGTx CFO & COO Richard Giroux vested 310,000 restricted share units and subsequently sold 163,916 shares to cover tax obligations.

MeiraGTx Holdings plc's President and CEO, Alexandria Forbes, reported the future vesting of 310,000 restricted share units and the withholding of 163,916 shares for tax purposes, effective January 17, 2026.

MeiraGTx Chief Medical Officer Robert K. Zeldin's direct beneficial ownership of ordinary shares adjusted to 147,291 following the vesting of 17,500 restricted share units and subsequent tax withholding.

MeiraGTx General Counsel Robert J. Wollin vested 7,500 restricted share units and subsequently sold 4,364 shares to cover tax obligations.

MeiraGTx Holdings plc's Chief Development Officer, Stuart Naylor, reported the vesting of restricted share units and subsequent tax-related share disposition.

MeiraGTx Holdings plc's CFO & COO, Richard Giroux, reported the vesting of 52,500 restricted share units and the subsequent sale of 28,822 shares for tax purposes.

MeiraGTx Holdings plc's President and CEO, Alexandria Forbes, reported the vesting of 62,500 restricted share units and a subsequent sale of 34,074 shares for tax obligations.

Perceptive Advisors, a 10% owner and director, has filed a Form 4 disclosing a planned sale of 2.3 million MeiraGTx Holdings plc ordinary shares at $7.91 per share on December 31, 2025, under a Rule 10b5-1 plan.

MeiraGTx Holdings plc President and CEO, Alexandria Forbes, reported a gift of 6,250 ordinary shares under a pre-arranged 10b5-1 plan.

MeiraGTx Holdings plc's General Counsel and Secretary, Robert J. Wollin, reported gifting 5,000 ordinary shares on November 20, 2025.

Richard Giroux, CFO and COO of MeiraGTx Holdings plc, sold 24,000 ordinary shares for a weighted average price of $8.87 per share under a Rule 10b5-1 trading plan.

MeiraGTx Holdings plc's President and CEO, Alexandria Forbes, sold 47,500 ordinary shares for a weighted average price of $8.39 per share, executed under a pre-arranged 10b5-1 trading plan.

MeiraGTx Holdings plc's CFO and COO, Richard Giroux, has filed a Form 4 indicating a pre-planned sale of 24,000 ordinary shares in July 2025 under a Rule 10b5-1 trading plan.

MeiraGTx Holdings plc's President and CEO, Alexandria Forbes, has filed a Form 4 indicating a planned sale of 47,500 ordinary shares on July 8, 2025, under a pre-arranged Rule 10b5-1 trading plan.

MeiraGTx Holdings plc's CFO and COO, Richard Giroux, reported a planned gift of 5,000 ordinary shares to his spouse, reducing his direct beneficial ownership.

MeiraGTx Holdings plc Director Debra Yu was granted 45,000 restricted share units on June 12, 2025, which will vest by June 2026.

MeiraGTx Holdings plc Director Thomas E. Shenk was granted 45,000 Restricted Share Units, which will convert into ordinary shares upon settlement and vest by June 2026.

MeiraGTx Holdings plc director Nicole Seligman was granted 45,000 Restricted Share Units (RSUs) as part of her compensation, aligning her interests with shareholders.

MeiraGTx Holdings plc Director Neil Mendoza has been granted 45,000 Restricted Share Units (RSUs) as part of his compensation, aligning his interests with shareholders.

MeiraGTx Holdings plc announced that Director Ellen Hukkelhoven was granted 45,000 Restricted Share Units, aligning her interests with shareholders.

MeiraGTx Holdings plc Director Keith R. Harris has filed an amended Form 4 to correct the reported number of restricted share units granted on June 12, 2025, now accurately reflecting 75,000 units.

MeiraGTx Holdings plc Director and 10% Owner Keith R. Harris reported the acquisition of 45,000 Restricted Share Units on June 12, 2025, which are set to vest in 2026.

Perceptive Advisors LLC, Perceptive Life Sciences Master Fund Ltd., and Joseph Edelman have reported the acquisition of 45,000 Restricted Share Units in MeiraGTx Holdings plc as part of director compensation.

MeiraGTx Holdings plc Director Keith R. Harris acquired 75,000 ordinary shares on June 6, 2025, through the vesting of restricted share units, increasing his direct beneficial ownership to 125,000 shares.

Richard Giroux, CFO & COO of MeiraGTx Holdings plc, sold 24,000 ordinary shares at an average price of $6, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Alexandria Forbes, President and CEO of MeiraGTx Holdings plc, sold 47,500 ordinary shares at an average price of $5.34 per share on April 8, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Richard Giroux, CFO & COO of MeiraGTx Holdings plc, reports the acquisition of 950,000 restricted share units on April 3, 2025.

Robert K. Zeldin, Chief Medical Officer of MeiraGTx Holdings plc, reports the acquisition of 90,000 restricted share units on April 3, 2025.

Alexandria Forbes, President & CEO of MeiraGTx Holdings plc, reports the acquisition of 950,000 restricted share units convertible into ordinary shares, with vesting occurring over the next four years.

Robert J. Wollin, General Counsel and Secretary of MeiraGTx Holdings plc, reports the acquisition of 100,000 restricted share units on April 3, 2025.